C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/00 (2006.01) C12Q 1/68 (2006.01) G01N 33/554 (2006.01) G01N 33/566 (2006.01) G01N 33/567 (2006.01) G01N 33/574 (2006.01)
Patent
CA 2369183
The invention provides a method for determining whether a treatment is effective in changing the status of a certain set of target cells, such as a tumor, in a patient. This method implies obtaining a sample from a patient after initiation of a treatment, and determining whether said sample comprises an expression product of at least one marker gene. Preferably, said sample is a blood sample. In one aspect, said expression product is expressed by a peripheral blood mononuclear cell. Said marker gene may be a gene involved in the generation, maintenance and/or breakdown of blood vessels (angiogenesis). A method of the invention is vary suitable to determine within a few days if a certain treatment against Kaposi's Sarcoma is successful. Moreover, this method is suitable for determining the presence of angiogenesis and/or tumor cells in a patient.
Cornelissen Marion
Van Der Kuyl Antoinette Cornelia
Amsterdam Support Diagnostics B.v.
Borden Ladner Gervais Llp
Primagen Holding B.v.
LandOfFree
Means and methods for treatment evaluation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Means and methods for treatment evaluation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Means and methods for treatment evaluation will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1755575